Skip to main content
. 2017 Mar 8;8(17):28237–28246. doi: 10.18632/oncotarget.16000

Table 1. Baseline characteristics of the patients.

Characteristics Values
Number 20
Demography
 Age (year) 54.2 ± 15.8
 Male (no. %) 10 (50)
 Body-mass index 21.1 ± 3.8
Clinical characteristics
 Diagnosis to transplantation (months) 30.8 ± 33.1
 SBP (mmHg) 96.5 ± 11.8
 Heart rate 79.1 ± 14.9
 Medication history
 Antiplatelet (no.%) 4 (20)
 Digoxin (no. %) 16 (80)
 ACEI/ARB (no.%) 10 (50)
 Diuretic (no.%) 20 (100)
 β-blockers (no.%) 16 (80)
 Antiarrhythmic (no.%) 10 (50)
Cardiac function
 I (no.%) 0
 II (no.%) 5 (25)
 III (no.%) 0
 IV (no.%) 15 (75)
Hypertension 0
Diabetes 0
Hyperlipidemia 4 (20)
ECG
 AF 5 (25)
 LBBB 0
 RBBB 4 (20)
 PVT 4 (20)
UCG
 LAD (mm) 46.9 ± 5.8
 LVEDD (mm) 67.9 ± 5.9
 EF (%) 31.3 ± 5.6
 MR (%) 20 (100)

ECG: electrocardiogram; AF: atrial fibrillation; LBBB: left bundle branch block; RBBB: right bundle branch block; PVT: paroxysmal ventricular tachycardia; UCG: ultrasonic cardiogram; LAD: left atrial diameter; LVEDD: Left ventricular end diastolic diameter; EF: Ejection fraction; MR: Mitral regurgitation (moderately to severe).